[1. .Wu Y, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol. 2008;7:373-377.]Search in Google Scholar
[2. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31:1000-1006.10.1093/eurheartj/ehp567289473620037179]Search in Google Scholar
[3. Jamnitski A, Symmons D, Peters MJ, et al. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis. 2013;72:211-216.10.1136/annrheumdis-2011-20119422532629]Search in Google Scholar
[4. Ramonda R, Lo Nigro A, Modesti V, et al. Atherosclerosis in psoriatic arthritis. Autoimmun Rev. 2011;10:773-778.10.1016/j.autrev.2011.05.02221684355]Search in Google Scholar
[5. Kimhi O, Caspi D, Bornstein NM, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum. 2007;36:203-209.10.1016/j.semarthrit.2006.09.00117067658]Search in Google Scholar
[6. Vitale C, Marazzi G, Volterrani M, et al. Metabolic syndrome. Minerva Med. 2006;97:219-229.]Search in Google Scholar
[7. Raychaudhuri SK, Chatterjee S, Nguyen C, et al. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metabolic Syndrome and Related Disorders. 2010;8:331-334.10.1089/met.2009.0124312970120367239]Search in Google Scholar
[8. Toms TE, Panoulas VF, John H, Douglas KM, Kitas GD. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther. 2009;11:R110.10.1186/ar2765274579219607680]Search in Google Scholar
[9. Karimi M, Mazloomzadeh S, Kafan S, Amirmoghadami H. The frequency of metabolic syndrome in women with rheumatoid arthritis and in controls. Int J Rheum Dis. 2011;14:248-254.10.1111/j.1756-185X.2011.01595.x21816020]Search in Google Scholar
[10. Karakoca M, Batmaza I, Sariyildiza MA, et al. The Relationship of Metabolic Syndrome With Disease Activity and the Functional Status in Patients With Rheumatoid Arthritis. J Clin Med Res. 2012;4:279-285.10.4021/jocmr1001w340962422870176]Search in Google Scholar
[11. Mok CC, Ko GTC, Ho LY, Yu KL, Chan PT. Prevalence of Atherosclerotic Risk Factors and the Metabolic Syndrome in Patients With Chronic Inflammatory Arthritis. Arthritis Care & Research. 2011,63:195-202.10.1002/acr.2036320890981]Search in Google Scholar
[12. Matei C., Pop I., Jurcuț R, et al. Romanian Multicentric Study of the Prevalence of Metabolic Syndrome - ROMES, Hellenic Journal of Cardiology, 2008: 49: 303-309.]Search in Google Scholar
[13. Tracy Y. Zhu, Edmund K. Li, Lai-Shan Tam. Cardiovascular Risk in Patients with Psoriatic Arthritis. Int J Rheumatol. 2012; 2012:714321.]Search in Google Scholar
[14. Madanagobalane S , Anandan S . Prevalence of metabolic syndrome in south Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: A hospital-based case-control study. Indian Journal of Dermatology. 2012;27:353-357.]Search in Google Scholar
[15. Sahebari M, Goshayeshi L, Mirfeizi Z, et al. Investigation of the Association between Metabolic Syndrome and Disease Activity in Rheumatoid Arthritis. The Scientific World Journal, 2011;11:1195-1205.10.1100/tsw.2011.111572008421666989]Search in Google Scholar
[16. Sattar N, McCarey D, Capell H, McInnes I. Explaining how ‘highgrade’ systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-2963.10.1161/01.CIR.0000099844.31524.0514676136]Search in Google Scholar
[17. Chung CP, Oeser A, Solus JF, et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196:756-763.10.1016/j.atherosclerosis.2007.01.00417266963]Search in Google Scholar
[18. Karvounaris SA, Sidiropoulos PI, Papadakis JA, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 2007;66:28-33.10.1136/ard.2006.053488179840616793841]Search in Google Scholar
[19. Escalante A, Haas R, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005; 165:1624-1629.10.1001/archinte.165.14.162416043681]Search in Google Scholar